[License-review] January 2020 License-Review Summary

Travin Keith travin.keith at opensource.org
Fri May 15 18:02:59 UTC 2020

Hello all,
In January, the License-Review mailing list went over the following:

   - Continued discussion on the Mulan PSL V2
   - Continued discussion on the Cryptographic Autonomy License (Beta 4)
   - Resolution of the Vaccine License – Not Approved
   - Continued discussion on the BSD-1-Clause [Legacy]
   - Resolution of the CasperLabs Open Source License (COSL) – Considered

*Continued discussion on the Mulan PSL V2*

Suggested improvements to the text in the license in around grammar,
clarity of intentions, and legal matters

Revised license submission

*Continued discussion on the Cryptographic Autonomy License (Beta 4)*

Questions on the license use, promulgation, and contributions

Issue regarding proprietary relicensing seemingly being the primary use case

Questions with regards to OSD compliance and user freedom, as well as
further viewpoints and considerations with regards to data exportability

Statement that it is OSD compliant and that arguments against it are too

*Resolution of the Vaccine License – Not Approved*

Decision that the Vaccine License does not conform to the OSD, specifically
OSD 5 regarding user discrimination, and does not assure user freedom.

*Continued discussion on the BSD-1-Clause [Legacy]*

Argument that all that use the license should just be relicensed under the
BSD License since multiple identical licenses hinders freedom due to their

Clarification that as a legacy submission, the submitter has no power over
the license and that there are significant logistical issues with regards
to push a change

*Resolution of the CasperLabs Open Source License (COSL) – Considered

Decision that the license is considered withdrawn due to non-responsiveness
and the criticisms that were brought up
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.opensource.org/pipermail/license-review_lists.opensource.org/attachments/20200515/91feb178/attachment-0001.html>

More information about the License-review mailing list